TY - JOUR
T1 - Spontaneous bilateral femoral fractures after high-dose zoledronic acid
AU - Brin, Yaron S.
AU - Palmanovich, Ezequiel
AU - Heler, Ziv
AU - Kish, Benyamin Josef
AU - Nyska, Meir
AU - Bismuth, Henry
AU - Coughlin, Ryan
AU - Zehavi, Tanya
AU - Rotman, Pnina
PY - 2015/11
Y1 - 2015/11
N2 - The authors report a case of spontaneous bilateral diaphyseal femoral fractures believed to be caused by oversuppression of bone remodeling as a result of long-term, high-dose treatment with bisphosphonate. The patient reported pain in both thighs before the fractures. Typical pathologic changes appeared on both femoral radiograph and bone scan before the fractures. Several hours after admission to the emergency department of the authors' institution, the patient underwent closed re-duction and internal fixation with intramedullary nails for the bilateral femoral diaphyseal fractures. Treatment with zoledronic acid was immediately discontinued. In recent years, low-energy femoral diaphyseal fractures in patients undergoing long-term bisphosphonate treatment have been reported. It is believed that the prolonged treatment causes long-term suppression of bone remodeling and accumulation of microdamage. It is important to observe patients who are undergoing bisphosphonate treatment carefully. In this case study, the authors report the patient's unique medical history.
AB - The authors report a case of spontaneous bilateral diaphyseal femoral fractures believed to be caused by oversuppression of bone remodeling as a result of long-term, high-dose treatment with bisphosphonate. The patient reported pain in both thighs before the fractures. Typical pathologic changes appeared on both femoral radiograph and bone scan before the fractures. Several hours after admission to the emergency department of the authors' institution, the patient underwent closed re-duction and internal fixation with intramedullary nails for the bilateral femoral diaphyseal fractures. Treatment with zoledronic acid was immediately discontinued. In recent years, low-energy femoral diaphyseal fractures in patients undergoing long-term bisphosphonate treatment have been reported. It is believed that the prolonged treatment causes long-term suppression of bone remodeling and accumulation of microdamage. It is important to observe patients who are undergoing bisphosphonate treatment carefully. In this case study, the authors report the patient's unique medical history.
UR - http://www.scopus.com/inward/record.url?scp=84946919683&partnerID=8YFLogxK
U2 - 10.3928/01477447-20151020-16
DO - 10.3928/01477447-20151020-16
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84946919683
SN - 0147-7447
VL - 38
SP - e1051-e1054
JO - Orthopedics
JF - Orthopedics
IS - 11
ER -